Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma

Published:2021-11 Issue: Volume:Volume 8 Page:1445-1458
ISSN:2253-5969
Container-title:Journal of Hepatocellular Carcinoma
language:en
Short-container-title:JHC

Author:

Huang Jingjun^ORCID,Huang Wensou^ORCID,Zhan Meixiao,Guo Yongjian,Liang Licong,Cai Mingyue,Lin Liteng,He Mingji,Lian Hui^ORCID,Lu Ligong,Zhu Kangshun^ORCID

Publisher

Informa UK Limited

Subject

General Medicine

Reference43 articles.

1. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

2. Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma

3. Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma

4. Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study

5. Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic Arterial Infusion Chemotherapy Combined Lenvatinib and PD-1 Inhibitor Showed Improved Survival for Infiltrative Hepatocellular Carcinoma: A Multicenter Cohort Study;Journal of Hepatocellular Carcinoma;2024-09

2. Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective Study;ImmunoTargets and Therapy;2024-08

3. Efficacy and Safety of Transarterial Chemoembolization and Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib in Treating Massive Hepatocellular Carcinoma;2024-07-24

4. Comparison of Transarterial Chemoembolization vs Radioembolization for Large Unresectable Hepatocellular Carcinoma (>8cm): A Propensity Score Matching Analysis.;2024-07-18

5. Multimodal treatment confers best overall survival results in patients with huge hepatocellular carcinoma: a systematic review and network meta-analysis;HPB;2024-07